GH Research GHRS
NASDAQ GHRS
$19.02 -0.15 (-0.76%)
As of: Oct 21, 2026 · 1:07 PM EDT

GH Research (GHRS) Receivables - Other (2023 - 2024)

Updated

GH Research's Receivables - Other was $1.58 million in Q4 2024, compared with $119,000 a year earlier.

Analysis

GH Research (GHRS) Receivables - Other (2023 - 2024) Analysis & Trends

  • In earlier years, Receivables - Other was $119,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn
10 GH Research 1.16 Bn 34.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.58 Mn
Dec 31, 2023 119,000.00
API Access

GH Research Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=GHRS&period=max&api_key=YOUR_API_KEY